R-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
申请人:Rogers Thomas
公开号:US20050020505A1
公开(公告)日:2005-01-27
The present invention relates to a class of compounds represented by the Formula I
or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the α
v
β
3
and/or the α
v
β
5
integrin without significantly inhibiting the α
v
β
6
integrin.
本发明涉及一类由公式I表示的化合物或其药学上可接受的盐,包括公式I化合物的制药组合物,以及选择性抑制或拮抗αvβ3和/或αvβ5整合素而不显著抑制αvβ6整合素的方法。